1 |
Israel-Assayag E, Fournier E, Cormier Y: Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis. J Immunol 163;6794- 6799, 1999
|
2 |
Gudmundsson G, Monick MM, Hunninghake GW: Viral infection modulates expression of hypersensitivity pneumonitis. J Immunol 162;7397-7401, 1999
|
3 |
Park Y, Oh SJ, Chung DH: CD4(+)CD25(+) regulatory T cells attenuate hypersensitivity pneumonitis by suppressing IFN-gamma production by CD4(+) and CD8(+) T cells. J Leukoc Biol 86;1427-1437, 2009
DOI
ScienceOn
|
4 |
Schatz M, Patterson R, Fink J: Immunopatholgenesis of hypersensitivity pneumonitis. J Allergy Clin Immunol 60;27-37, 1977
DOI
|
5 |
Patel AM, Ryu JH, Reed CE: Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 108;661-670, 2001
DOI
ScienceOn
|
6 |
Girard M, Israel-Assayag E, Cormier Y: Pathogenesis of hypersensitivity pneumonitis. Curr Opin Allergy Clin Immunol 4;93-98, 2004
DOI
ScienceOn
|
7 |
Irifune K, Yokoyama A, Kohno N, Sakai K, Hiwada K: T-helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice. Eur Respir J 21;11-18, 2003
DOI
ScienceOn
|
8 |
Gudmundsson G, Hunninghake GW: Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest 99;2386-2390, 1997
DOI
ScienceOn
|
9 |
Mohr LC: Hypersensitivity pneumonitis. Curr Opin Pulm Med 10;401-411, 2004
DOI
ScienceOn
|
10 |
Ghadirian E, Denis M: Murine hypersensitivity pneumonitis: interleukin-4 administration partially abrogates the disease process. Microb Pathog 12;377-382, 1992
DOI
ScienceOn
|
11 |
Schuyler M, Gott K, Cherne A: Mediators of hypersensitivity pneumonitis. J Lab Clin Med 136;29-38, 2000
DOI
ScienceOn
|
12 |
Denis M: Proinflammatory cytokines in hypersensitivity pneumonitis. Am J Respir Crit Care Med 151;164-169, 1995
DOI
ScienceOn
|
13 |
Nance S, Cross R, Yi AK, Fitzpatrick EA: IFN-gamma production by innate immune cells is sufficient for development of hypersensitivity pneumonitis. Eur J Immunol 35; 1928-1938, 2005
DOI
ScienceOn
|
14 |
Hwang SJ, Kim S, Park WS, Chung DH: IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-gamma-producing neutrophils. J Immunol 177;5258- 5268, 2006
|
15 |
Nimmerjahn F, Ravetch JV: Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8;34-47, 2008
DOI
ScienceOn
|
16 |
Beaven MA, Metzger H: Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol Today 14;222-226, 1993
DOI
ScienceOn
|
17 |
Nimmerjahn F, Ravetch JV: Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310;1510-1512, 2005
DOI
ScienceOn
|
18 |
Nimmerjahn F: Activating and inhibitory FcgammaRs in autoimmune disorders. Springer Semin Immunopathol 28;305- 319, 2006
DOI
ScienceOn
|
19 |
Nimmerjahn F, Ravetch JV: Fcgamma receptors: old friends and new family members. Immunity 24;19-28, 2006
DOI
ScienceOn
|
20 |
Ravetch JV, Bolland S: IgG Fc receptors. Annu Rev Immunol 19;275-290, 2001
DOI
ScienceOn
|
21 |
Uchida J, Hamaguchi Y, Oliver JA, Ravetch JV, Poe JC, Haas KM, Tedder TF: The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med 199;1659-1669, 2004
DOI
ScienceOn
|
22 |
Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV: FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76;519-529, 1994
DOI
ScienceOn
|
23 |
Clynes R, Takechi Y, Moroi Y, Houghton A, Ravetch JV: Fc receptors are required in passive and active immunity to melanoma. Proc Natl Acad Sci U S A 95;652-656, 1998
DOI
ScienceOn
|
24 |
Clynes R, Ravetch JV: Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 3;21-26, 1995
DOI
ScienceOn
|
25 |
McSharry C, Anderson K, Boyd G: A review of antigen diversity causing lung disease among pigeon breeders. Clin Exp Allergy 30;1221-1229, 2000
DOI
ScienceOn
|
26 |
Reynolds SP, Edwards JH, Jones KP, Davies BH: Immunoglobulin and antibody levels in bronchoalveolar lavage fluid from symptomatic and asymptomatic pigeon breeders. Clin Exp Immunol 86;278-285, 1991
|
27 |
Drent M, van Velzen-Blad H, Diamant M, Wagenaar SS, Hoogsteden HC, van den Bosch JM: Bronchoalveolar lavage in extrinsic allergic alveolitis: effect of time elapsed since antigen exposure. Eur Respir J 6;1276-1281, 1993
|
28 |
Semenzato G, Agostini C, Zambello R, Trentin L, Chilosi M, Pizzolo G, Marcer G, Cipriani A: Lung T cells in hypersensitivity pneumonitis: phenotypic and functional analyses. J Immunol 137;1164-1172, 1986
|
29 |
Oshima M, Maeda A, Ishioka S, Hiyama K, Yamakido M: Expression of C-C chemokines in bronchoalveolar lavage cells from patients with granulomatous lung diseases. Lung 177;229-240, 1999
DOI
ScienceOn
|
30 |
Nance S, Cross R, Fitzpatrick E: Chemokine production during hypersensitivity pneumonitis. Eur J Immunol 34;677- 685, 2004
DOI
ScienceOn
|
31 |
Schuyler M, Cormier Y: The diagnosis of hypersensitivity pneumonitis. Chest 111;534-536, 1997
DOI
ScienceOn
|
32 |
Hisauchi-Kojima K, Sumi Y, Miyashita Y, Miyake S, Toyoda H, Kurup VP, Yoshizawa Y: Purification of the antigenic components of pigeon dropping extract, the responsible agent for cellular immunity in pigeon breeder's disease. J Allergy Clin Immunol 103;1158-1165, 1999
DOI
ScienceOn
|
33 |
Woda BA: Hypersensitivity pneumonitis: an immunopathology review. Arch Pathol Lab Med 132;204-205, 2008
|
34 |
Ravetch JV, Clynes RA: Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 16;21-132, 1998
|
35 |
Suga M, Yamasaki H, Nakagawa K, Kohrogi H, Ando M: Mechanisms accounting for granulomatous responses in hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis 14;131-138, 1997
|
36 |
Schuyler M, Gott K, Edwards B: Th1 cells that adoptively transfer experimental hypersensitivity pneumonitis are activated memory cells. Lung 177;377-389, 1999
DOI
ScienceOn
|
37 |
Takai T: Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2;580-592, 2002
DOI
|
38 |
Koyasu S: CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4−CD− and gamma-delta TCR+CD4−CD8− cells. J Exp Med 179;1957-1972, 1994
DOI
ScienceOn
|
39 |
Bendelac A: CD1: presenting unusual antigens to unusual T lymphocytes. Science 269;185-186, 1995
DOI
|
40 |
Kim HY, Kim S, Chung DH: FcgammaRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation. J Clin Invest 116;2484-2492, 2006
|